Ultragenyx Pharmaceutical Inc. Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for July 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15 2020 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 85.35 | 40,000 | 3,414,000 | 2,419,741 | 2.5 M to 2.4 M (-1.63 %) |
| Jul 10 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Option Exercise | M | 21.00 | 2,000 | 42,000 | 12,000 | |
| Jul 10 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Sell | S | 91.00 | 2,000 | 182,000 | 16,582 | 18.6 K to 16.6 K (-10.76 %) |
| Jul 10 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Buy | M | 21.00 | 2,000 | 42,000 | 18,582 | 16.6 K to 18.6 K (+12.06 %) |
| Jul 10 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Sell | S | 91.00 | 638 | 58,058 | 16,582 | 17.2 K to 16.6 K (-3.70 %) |
| Jul 08 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | M | 21.00 | 6,181 | 129,801 | 0 | |
| Jul 08 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Sell | S | 90.00 | 6,181 | 556,290 | 13,550 | 19.7 K to 13.6 K (-31.33 %) |
| Jul 08 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Buy | M | 21.00 | 6,181 | 129,801 | 19,731 | 13.6 K to 19.7 K (+45.62 %) |
| Jul 08 2020 | RARE | Ultragenyx Pharmac ... | Harris Erik | EVP & Chief Commerc ... | Payment of Exercise | F | 86.75 | 260 | 22,555 | 23,590 | 23.9 K to 23.6 K (-1.09 %) |
| Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | M | 21.00 | 5,000 | 105,000 | 6,181 | |
| Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Sell | S | 85.00 | 5,000 | 425,000 | 13,550 | 18.6 K to 13.6 K (-26.95 %) |
| Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Buy | M | 21.00 | 5,000 | 105,000 | 18,550 | 13.6 K to 18.6 K (+36.90 %) |
| Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Option Exercise | M | 21.00 | 1,500 | 31,500 | 14,000 | |
| Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Sell | S | 81.00 | 1,500 | 121,500 | 17,220 | 18.7 K to 17.2 K (-8.01 %) |
| Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Buy | M | 21.00 | 1,500 | 31,500 | 18,720 | 17.2 K to 18.7 K (+8.71 %) |
| Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Sell | S | 81.00 | 1,111 | 89,991 | 17,220 | 18.3 K to 17.2 K (-6.06 %) |